We are live on
!
Find out more
EA
Everpar Advisors Portfolio holdings
AUM
$352M
1-Year Est. Return
37.56%
This Fund
S&P 500
This Quarter
Est. Return
+12.1%
1 Year Est. Return
+37.56%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$220M
AUM Growth
+$31.7M
(+17%)
Cap. Flow
+$13.8M
Cap. Flow
% of AUM
6.29%
Top 10 Holdings %
Top 10 Hldgs %
30.09%
Holding
276
New
24
Increased
135
Reduced
96
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.36M |
| 2 |
Microsoft
MSFT
|
+$868K |
| 3 |
NVIDIA
NVDA
|
+$832K |
| 4 |
Capital Group Growth ETF
CGGR
|
+$766K |
| 5 |
Capital Group Dividend Value ETF
CGDV
|
+$682K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xylem
XYL
|
+$366K |
| 2 |
Teradyne
TER
|
+$357K |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$286K |
| 4 |
Coca-Cola
KO
|
+$280K |
| 5 |
Charles River Laboratories
CRL
|
+$276K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Financials | 14.39% |
| 3 | Consumer Discretionary | 7.46% |
| 4 | Industrials | 7.43% |
| 5 | Healthcare | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
276
Xylem
XYL
$29.2B
| – | – |
-3,064
| Closed | -$366K |
|
Similar funds
ES
HIA
VR
CGFA
AW
ACA
PIC
FFO
Everpar Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Everpar Advisors held 276 positions worth $220M, up 17% from $188M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Everpar Advisors deployed $13.8M of net new capital in Q2 2025, opening 24 new positions and adding to 135 existing holdings. Its largest new stake was Gilead Sciences: 3,012 shares worth $334K.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $286K trimmed.
- Everpar Advisors's largest Q2 2025 buy was Gilead Sciences: 3,012 shares worth $334K.
- Everpar Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $2.36M increase.
- Everpar Advisors's biggest Q2 2025 reduction was Alphabet (Google) Class C, cutting an estimated $286K.
- Everpar Advisors fully exited Xylem in Q2 2025, selling an estimated $366K.
- Everpar Advisors's ten largest holdings make up 30% of its $220M portfolio in Q2 2025.
- Everpar Advisors opened 24 new positions and closed 10 in Q2 2025.
- Everpar Advisors's portfolio value rose 17% quarter-over-quarter to $220M.
Based on Everpar Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.